Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation
Aim. To evaluate the budgetary impact of using budesonide + formoterol (Symbicort Turbuhaler) as maintenance therapy in real clinical practice compared with standard therapy for asthma of varying severity: for mild asthma with on-demand salbutamol; for moderate and severe asthma with the drug salme...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Russo |
| Pubblicazione: |
"Consilium Medicum" Publishing house
2022-08-01
|
| Serie: | Терапевтический архив |
| Soggetti: | |
| Accesso online: | https://ter-arkhiv.ru/0040-3660/article/viewFile/109735/83978 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
